click below
click below
Normal Size Small Size show me how
Endocrine drugs
Question | Answer |
---|---|
Propylthiouracil tox | skin rash,agranulocytosis, aplastic anemia, hepatotoxicity |
methimazole tox | teratogen, skin rash, agranulocytosis, aplastic anemia |
levothyroxine, triidothyronine | tachycardia, heat intolerance, tremors, arryhthmias |
GH use | Turner's syndrome, gh deficiency |
octreotide use | acromegaly, carcinoid syndrome, gastrinoma,gucagonoma |
oxytocin use | stimulates labor, uterine contractions, milk let-down, controls uterine hemorrhage |
ADH (desmopressin) use | CENtrAL pituitary DI |
demeclocycline use | SIADH |
rapid acting insulin | lispro aspart |
intermediate acting insulin | NPH |
long acting insulin | glargine, detemir |
MOA of insulin | binds insulin receptor (Tyrosine kinase activity) liver: increases glucose stored as glycogen muscle: increases glycogen and protein synthesis, K+ uptake fat: aids TG storage |
insulin tox | hypoglycemia, hypersensitivity reaction |
insulin use | life threatening hyperkalemia, stress induced hyperglycemia, Type 1 and 2 DM, gestational diabetes |
sulfonylureas tox | disulfiram like effects (first generation) hypoglycemia (second generation) |
first generation sulfonyureas | tolbutamide chlorpropramide |
second generation sulfonylureas | glyburide glimepiride glipizide |
MOA of sulfonylureas | close K+ channel in beta cell membrane -> cell depolarizes -> triggering of insulin release via increased Ca influx |
biguanide (metformin) | decreased glucoconeogenesis, increased glycolysis, increased peripheral glucose uptake (insulin sensitivity) |
can be used in patietns without islet function | metformin |
contraindicated in renal failure | metformin |
weight gain, edema, hepatotoxicity, heart failrue | pioglitazone, rosiglitazone |
glitazones/thiazolidinediones MOA | increases insulin sensitivity in peripehral tissue binds to PPAR gamma nuclear transcription regulator |
alpha glucosidase inhibitors | acarbose, miglitol |
inhibits intestinal brush border alpha glucosidases. Delayed sugar hydrolysis and glucose absorption -> decreased postprandial hyperglycemia | acarbose, miglitol |
pramlintide | hypoglycemia, nausea, diarrhea |
pramlintide MOA | decreases glucagon |
exenatide | increases insulin, decreases glucagon release |
pancreatitis | exenatide |